这是一篇来自已证抗体库的有关人类 PIK3CB的综述,是根据15篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合PIK3CB 抗体。
PIK3CB 同义词: P110BETA; PI3K; PI3KBETA; PIK3C1

圣克鲁斯生物技术
小鼠 单克隆(B-5)
  • 其他; 人类; 图 4c
圣克鲁斯生物技术 PIK3CB抗体(SantaCruz, sc-376412)被用于被用于其他在人类样本上 (图 4c). Cancer Cell (2018) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 小鼠; 图 2a
圣克鲁斯生物技术 PIK3CB抗体(Santa Cruz, sc-376492)被用于被用于免疫印迹在小鼠样本上 (图 2a). Cell Signal (2016) ncbi
小鼠 单克隆(D-4)
  • 免疫印迹; 人类; 1:200
圣克鲁斯生物技术 PIK3CB抗体(Santa Cruz Biotechnology Inc, sc-8010)被用于被用于免疫印迹在人类样本上浓度为1:200. PLoS ONE (2014) ncbi
艾博抗(上海)贸易有限公司
domestic rabbit 单克隆(EPR5515(2))
  • 免疫印迹; 小鼠; 1:1000; 图 5b
艾博抗(上海)贸易有限公司 PIK3CB抗体(Abcam, ab151549)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5b). Biosci Rep (2019) ncbi
domestic rabbit 单克隆(EPR5515(2))
  • 免疫印迹; 大鼠; 图 5d
艾博抗(上海)贸易有限公司 PIK3CB抗体(Abcam, ab151549)被用于被用于免疫印迹在大鼠样本上 (图 5d). Oxid Med Cell Longev (2017) ncbi
domestic rabbit 单克隆(EPR5515(2))
  • 免疫细胞化学; 人类; 1:50; 图 4
艾博抗(上海)贸易有限公司 PIK3CB抗体(Abcam, ab151549)被用于被用于免疫细胞化学在人类样本上浓度为1:50 (图 4). Biochem J (2016) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 单克隆(C33D4)
  • 免疫印迹; 人类; 1:1000; 图 3c
赛信通(上海)生物试剂有限公司 PIK3CB抗体(CST, 3011)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3c). J Cancer (2021) ncbi
domestic rabbit 单克隆(C33D4)
  • 免疫印迹; 小鼠; 1:1000; 图 1a
赛信通(上海)生物试剂有限公司 PIK3CB抗体(Cell Signaling, 3011)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 1a). Nat Commun (2019) ncbi
domestic rabbit 单克隆(C33D4)
  • 免疫印迹; 人类; 图 6a
赛信通(上海)生物试剂有限公司 PIK3CB抗体(Cell signaling, 3011s)被用于被用于免疫印迹在人类样本上 (图 6a). Cancer Med (2017) ncbi
domestic rabbit 单克隆(C33D4)
  • 免疫印迹; 人类; 1:1000; 图 6c
赛信通(上海)生物试剂有限公司 PIK3CB抗体(Cell Signaling, C33D4)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6c). Nat Commun (2016) ncbi
domestic rabbit 单克隆(C33D4)
  • 免疫印迹基因敲除验证; 小鼠; 图 1
赛信通(上海)生物试剂有限公司 PIK3CB抗体(Cell Signaling, 3011)被用于被用于免疫印迹基因敲除验证在小鼠样本上 (图 1). elife (2016) ncbi
domestic rabbit 单克隆(C33D4)
  • 免疫印迹; 人类; 图 s1
赛信通(上海)生物试剂有限公司 PIK3CB抗体(Cell Signaling, 3011)被用于被用于免疫印迹在人类样本上 (图 s1). Cell Discov (2016) ncbi
domestic rabbit 单克隆(C33D4)
  • 免疫印迹; 人类; 图 4c
赛信通(上海)生物试剂有限公司 PIK3CB抗体(Cell Signaling, C33D4)被用于被用于免疫印迹在人类样本上 (图 4c). Oncotarget (2016) ncbi
domestic rabbit 单克隆(C33D4)
  • 免疫印迹; 人类; 图 4
赛信通(上海)生物试剂有限公司 PIK3CB抗体(Cell Signaling, 3011)被用于被用于免疫印迹在人类样本上 (图 4). Oncotarget (2016) ncbi
domestic rabbit 单克隆(C33D4)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 PIK3CB抗体(Cell Signaling, C33D4)被用于被用于免疫印迹在人类样本上. Mol Cell Biol (2014) ncbi
文章列表
  1. Lin G, Li J, Cai J, Zhang H, Xin Q, Wang N, et al. RNA-binding Protein MBNL2 regulates Cancer Cell Metastasis through MiR-182-MBNL2-AKT Pathway. J Cancer. 2021;12:6715-6726 pubmed 出版商
  2. You Y, Qin Z, Zhang H, Yuan Z, Yu X. MicroRNA-153 promotes brain-derived neurotrophic factor and hippocampal neuron proliferation to alleviate autism symptoms through inhibition of JAK-STAT pathway by LEPR. Biosci Rep. 2019;: pubmed 出版商
  3. Araiz C, Yan A, Bettedi L, Samuelson I, Virtue S, McGavigan A, et al. Enhanced β-adrenergic signalling underlies an age-dependent beneficial metabolic effect of PI3K p110α inactivation in adipose tissue. Nat Commun. 2019;10:1546 pubmed 出版商
  4. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed 出版商
  5. Gomes J, Fernandes T, Soci U, Silveira A, Barretti D, Negrao C, et al. Obesity Downregulates MicroRNA-126 Inducing Capillary Rarefaction in Skeletal Muscle: Effects of Aerobic Exercise Training. Oxid Med Cell Longev. 2017;2017:2415246 pubmed 出版商
  6. Liu S, Gao G, Yan D, Chen X, Yao X, Guo S, et al. Effects of miR-145-5p through NRAS on the cell proliferation, apoptosis, migration, and invasion in melanoma by inhibiting MAPK and PI3K/AKT pathways. Cancer Med. 2017;6:819-833 pubmed 出版商
  7. Yang J, Savvatis K, Kang J, Fan P, Zhong H, Schwartz K, et al. Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment. Nat Commun. 2016;7:13710 pubmed 出版商
  8. Cizmecioglu O, Ni J, Xie S, Zhao J, Roberts T. Rac1-mediated membrane raft localization of PI3K/p110? is required for its activation by GPCRs or PTEN loss. elife. 2016;5: pubmed 出版商
  9. Yuzugullu H, Von T, Thorpe L, Walker S, Roberts T, Frank D, et al. NTRK2 activation cooperates with PTEN deficiency in T-ALL through activation of both the PI3K-AKT and JAK-STAT3 pathways. Cell Discov. 2016;2:16030 pubmed 出版商
  10. Jacobsen R, Mazloumi Gavgani F, Mellgren G, Lewis A. DNA Topoisomerase II? contributes to the early steps of adipogenesis in 3T3-L1 cells. Cell Signal. 2016;28:1593-603 pubmed 出版商
  11. Monica V, Lo Iacono M, Bracco E, Busso S, di Blasio L, Primo L, et al. Dasatinib modulates sensitivity to pemetrexed in malignant pleural mesothelioma cell lines. Oncotarget. 2016;7:76577-76589 pubmed 出版商
  12. Karlsson T, Altankhuyag A, Dobrovolska O, Turcu D, Lewis A. A polybasic motif in ErbB3-binding protein 1 (EBP1) has key functions in nucleolar localization and polyphosphoinositide interaction. Biochem J. 2016;473:2033-47 pubmed 出版商
  13. Lynch J, McEwen R, Crafter C, McDermott U, Garnett M, Barry S, et al. Identification of differential PI3K pathway target dependencies in T-cell acute lymphoblastic leukemia through a large cancer cell panel screen. Oncotarget. 2016;7:22128-39 pubmed 出版商
  14. Parenti R, Cardile V, Graziano A, Parenti C, Venuti A, Bertuccio M, et al. Wilms' tumor gene 1 (WT1) silencing inhibits proliferation of malignant peripheral nerve sheath tumor sNF96.2 cell line. PLoS ONE. 2014;9:e114333 pubmed 出版商
  15. Perez García V, Redondo Muñoz J, Kumar A, Carrera A. Cell activation-induced phosphoinositide 3-kinase alpha/beta dimerization regulates PTEN activity. Mol Cell Biol. 2014;34:3359-73 pubmed 出版商